0001209191-13-030730.txt : 20130605 0001209191-13-030730.hdr.sgml : 20130605 20130605135306 ACCESSION NUMBER: 0001209191-13-030730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130603 FILED AS OF DATE: 20130605 DATE AS OF CHANGE: 20130605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUSTAFSON KURT A CENTRAL INDEX KEY: 0001462354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 13893784 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-06-03 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001462354 GUSTAFSON KURT A 11500 S. EASTERN AVE. SUITE 240 HENDERSON NV 89052 0 1 0 0 EVP & Chief Financial Officer Common Stock, $0.001 par value 2013-06-03 4 A 0 100000 0.00 A 100000 D Stock Option (Right to Buy) 8.21 2013-06-03 4 A 0 250000 0.00 A 2014-06-03 2023-06-03 Common Stock 250000 250000 D 25% of the restricted shares will vest on June 3, 2014. The remaining restricted shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years. 25% of the option shares shall vest on June 3, 2014. The remaining option shares shall vest in equal monthly amounts on the anniversary date of the grant over three years. /s/ Brett L. Scott, attorney-in-fact for Kurt A. Gustafson 2013-06-05 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY



AUTHORIZATION


I hereby authorize Rajesh C. Shrotriya, Joseph K. Keller, Abraham N. Oler or
Brett L. Scott,
acting singly, to sign and file on my behalf any and all forms required by the
Securities and
Exchange Commission pursuant to Section 16 of the Securities Exchange Act of
1934
(the "Exchange Act") relating to the reporting of beneficial ownership of equity
securities of
Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and of
changes in such
beneficial ownership, together with any and all amendments thereto.  This
authorization shall
be effective on and after the date set forth below and shall continue in effect
until I am no
longer required to file such forms, unless earlier revoked by me in writing.

I acknowledge that the persons authorized hereunder are not assuming, nor is the
Company
assuming, any of my responsibilities to comply with Section 16 of the Exchange
Act.

Dated as of this 23rd day of May, 2013.



						 /s/ Kurt A. Gustafson
						Kurt A. Gustafson